Halifax Biomedical Overview

  • Founded
  • 2004
  • Status
  • Private
  • Employees
  • 11
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 3

Halifax Biomedical General Information


Operator of a biomedical institute intended to deliver contract research services and development of diagnostic medical equipment. The company's biomedical institute offers clinical trials such as ankle arthroplasty, knee arthroplasty, fracture fixation, hip arthroplasty, bone cement, modular total knee replacement, and spinal fusion devices, enabling doctors to cure patients effectively with the latest equipment and technologies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Services
Other Industries
Therapeutic Devices
Primary Office
  • PO Box 67
  • Mabou, Nova Scotia B0E 1X0
  • Canada
+1 (902) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Halifax Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 25-Jun-2014 00.00 Completed Generating Revenue
2. Later Stage VC 28-Oct-2011 000 00.00 Completed Generating Revenue
1. Debt - General 02-Apr-2008 $900K $900K Completed Startup
To view Halifax Biomedical’s complete valuation and funding history, request access »

Halifax Biomedical Executive Team (8)

Name Title Board Seat Contact Info
Chad Munro Founder, Chief Executive Officer, President & Board Member
Bob Poggie Ph.D Vice President of Clinical and Contract Research Services
Crystal Jones Vice President of Operations
You’re viewing 3 of 8 executive team members. Get the full list »

Halifax Biomedical Board Members (7)

Name Representing Role Since
Chad Munro Halifax Biomedical Founder, Chief Executive Officer, President & Board Member 000 0000
You’re viewing 1 of 7 board members. Get the full list »

Halifax Biomedical Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Halifax Biomedical Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
New Dawn Enterprises Other Minority 000 0000 000000 0
Enterprise Cape Breton Corporation Corporation Minority 000 0000 000000 0
NSBI Venture Capital Corporate Venture Capital Minority 000 0000 000000 0
To view Halifax Biomedical’s complete investors history, request access »